Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium

Seropositivity for the HPV16-E6 oncoprotein is a promising marker for early detection of oropharyngeal cancer (OPC), but the absolute risk of OPC after a positive or negative test is unknown. METHODS: We constructed an OPC risk prediction model that integrates (1) relative odds of OPC for HPV16-E6 s...

Descripción completa

Detalles Bibliográficos
Autores principales: Robbins, Hilary A., Ferreiro-Iglesias, Aida, Waterboer, Tim, Brenner, Nicole, Nygard, Mari, Bender, Noemi, Schroeder, Lea, Hildesheim, Allan, Pawlita, Michael, D'Souza, Gypsyamber, Visvanathan, Kala, Langseth, Hilde, Schlecht, Nicolas F., Tinker, Lesley F., Agalliu, Ilir, Wassertheil-Smoller, Sylvia, Ness-Jensen, Eivind, Hveem, Kristian, Grioni, Sara, Kaaks, Rudolf, Sánchez, Maria-Jose, Weiderpass, Elisabete, Giles, Graham G., Milne, Roger L., Cai, Qiuyin, Blot, William J., Zheng, Wei, Weinstein, Stephanie J., Albanes, Demetrius, Huang, Wen-Yi, Freedman, Neal D., Kreimer, Aimée R., Johansson, Mattias, Brennan, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622695/
https://www.ncbi.nlm.nih.gov/pubmed/35700419
http://dx.doi.org/10.1200/JCO.21.01785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622695/
https://www.ncbi.nlm.nih.gov/pubmed/35700419
http://dx.doi.org/10.1200/JCO.21.01785

Ejemplares similares